Therapeutic efficacy of theophylline in chronic lymphocytic leukemia

Della F. Makower, Ummekalsoom Malik, Yelena Novik, Peter H. Wiernik

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Theophylline, a methylxanthine commonly used as a treatment for asthma, has been shown to induce apoptosis in chronic lymphocytic leukemia (CLL) cells both in vitro and in vivo. We have treated three advanced CLL patients with theophylline, and seen responses in two. The clinical courses of the responders are presented, and the literature concerning theophylline as therapy for CLL is reviewed.

Original languageEnglish (US)
Pages (from-to)69-71
Number of pages3
JournalMedical Oncology
Volume16
Issue number1
StatePublished - Apr 1999

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Theophylline
Therapeutics
Asthma
Apoptosis

Keywords

  • Apoptosis
  • Chronic lymphocytic leukemia
  • Cyclic adenosine monophosphate
  • Methylxanthine
  • Theophylline

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Makower, D. F., Malik, U., Novik, Y., & Wiernik, P. H. (1999). Therapeutic efficacy of theophylline in chronic lymphocytic leukemia. Medical Oncology, 16(1), 69-71.

Therapeutic efficacy of theophylline in chronic lymphocytic leukemia. / Makower, Della F.; Malik, Ummekalsoom; Novik, Yelena; Wiernik, Peter H.

In: Medical Oncology, Vol. 16, No. 1, 04.1999, p. 69-71.

Research output: Contribution to journalArticle

Makower, DF, Malik, U, Novik, Y & Wiernik, PH 1999, 'Therapeutic efficacy of theophylline in chronic lymphocytic leukemia', Medical Oncology, vol. 16, no. 1, pp. 69-71.
Makower, Della F. ; Malik, Ummekalsoom ; Novik, Yelena ; Wiernik, Peter H. / Therapeutic efficacy of theophylline in chronic lymphocytic leukemia. In: Medical Oncology. 1999 ; Vol. 16, No. 1. pp. 69-71.
@article{c40ea0d01ec641969381847ce42f4673,
title = "Therapeutic efficacy of theophylline in chronic lymphocytic leukemia",
abstract = "Theophylline, a methylxanthine commonly used as a treatment for asthma, has been shown to induce apoptosis in chronic lymphocytic leukemia (CLL) cells both in vitro and in vivo. We have treated three advanced CLL patients with theophylline, and seen responses in two. The clinical courses of the responders are presented, and the literature concerning theophylline as therapy for CLL is reviewed.",
keywords = "Apoptosis, Chronic lymphocytic leukemia, Cyclic adenosine monophosphate, Methylxanthine, Theophylline",
author = "Makower, {Della F.} and Ummekalsoom Malik and Yelena Novik and Wiernik, {Peter H.}",
year = "1999",
month = "4",
language = "English (US)",
volume = "16",
pages = "69--71",
journal = "Medical Oncology and Tumor Pharmacotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "1",

}

TY - JOUR

T1 - Therapeutic efficacy of theophylline in chronic lymphocytic leukemia

AU - Makower, Della F.

AU - Malik, Ummekalsoom

AU - Novik, Yelena

AU - Wiernik, Peter H.

PY - 1999/4

Y1 - 1999/4

N2 - Theophylline, a methylxanthine commonly used as a treatment for asthma, has been shown to induce apoptosis in chronic lymphocytic leukemia (CLL) cells both in vitro and in vivo. We have treated three advanced CLL patients with theophylline, and seen responses in two. The clinical courses of the responders are presented, and the literature concerning theophylline as therapy for CLL is reviewed.

AB - Theophylline, a methylxanthine commonly used as a treatment for asthma, has been shown to induce apoptosis in chronic lymphocytic leukemia (CLL) cells both in vitro and in vivo. We have treated three advanced CLL patients with theophylline, and seen responses in two. The clinical courses of the responders are presented, and the literature concerning theophylline as therapy for CLL is reviewed.

KW - Apoptosis

KW - Chronic lymphocytic leukemia

KW - Cyclic adenosine monophosphate

KW - Methylxanthine

KW - Theophylline

UR - http://www.scopus.com/inward/record.url?scp=0033005763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033005763&partnerID=8YFLogxK

M3 - Article

C2 - 10382946

AN - SCOPUS:0033005763

VL - 16

SP - 69

EP - 71

JO - Medical Oncology and Tumor Pharmacotherapy

JF - Medical Oncology and Tumor Pharmacotherapy

SN - 0340-7004

IS - 1

ER -